Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis.
作者信息
Zilberberg Marya D, Nathanson Brian H, Sulham Kate, Fan Weihong, Shorr Andrew F
机构信息
EviMed Research Group, LLC, PO Box 303, Goshen, MA, 01032, USA.
OptiStatim, LLC, Longmeadow, MA, USA.
出版信息
Crit Care. 2017 Jun 5;21(1):130. doi: 10.1186/s13054-017-1719-9.
Abstract
摘要
相似文献
1
Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis.社区获得性鲍曼不动杆菌肺炎或脓毒症住院存活患者延迟接受充分抗生素治疗的每日成本。
Crit Care. 2017 Jun 5;21(1):130. doi: 10.1186/s13054-017-1719-9.
2
Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.中国住院低风险社区获得性肺炎患者护理中的成本节约潜力。
Value Health. 2009 Jan-Feb;12(1):40-6. doi: 10.1111/j.1524-4733.2008.00410.x. Epub 2008 Jul 10.
3
Antibiotic use in children hospitalised with pneumonia in Central Vietnam.越南北部儿童肺炎住院患者的抗生素使用情况。
Arch Dis Child. 2020 Aug;105(8):713-719. doi: 10.1136/archdischild-2019-317733. Epub 2020 Feb 20.
4
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis.鲍曼不动杆菌肺炎和脓毒症中的多重耐药性、不适当的经验性治疗及医院死亡率
Crit Care. 2016 Jul 11;20(1):221. doi: 10.1186/s13054-016-1392-4.
5
[Pneumonia in the antibiotic era].[抗生素时代的肺炎]
Zhonghua Jie He He Hu Xi Za Zhi. 1999 Apr;22(4):197-8.
6
7
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.医院获得性耐碳青霉烯鲍曼不动杆菌肺炎患者的危险因素和死亡率。
Am J Infect Control. 2013 Jul;41(7):e59-63. doi: 10.1016/j.ajic.2013.01.006. Epub 2013 Mar 21.
8
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis.克拉霉素可提高呼吸机相关性肺炎和脓毒症患者的长期生存率并带来成本效益。
Antimicrob Agents Chemother. 2016 May 23;60(6):3640-6. doi: 10.1128/AAC.02974-15. Print 2016 Jun.
9
Macrophage activation syndrome following Acinetobacter baumannii sepsis.鲍曼不动杆菌脓毒症后继发巨噬细胞活化综合征。
Int J Infect Dis. 2012 Mar;16(3):e223-4. doi: 10.1016/j.ijid.2011.12.002. Epub 2012 Jan 27.
10
Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.医院获得性鲍曼不动杆菌血流感染中多重耐药的临床和经济影响
Infect Control Hosp Epidemiol. 2007 Jun;28(6):713-9. doi: 10.1086/517954. Epub 2007 May 14.
引用本文的文献
1
At the Intersection of Critical Care and Infectious Diseases: The Year in Review.重症监护与传染病的交叉领域：年度回顾
Biomedicines. 2024 Mar 2;12(3):562. doi: 10.3390/biomedicines12030562.
2
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals.接受棘白菌素治疗的成年念珠菌血症或侵袭性念珠菌病住院患者的医疗资源利用情况及出院准备情况：美国医院分析
Open Forum Infect Dis. 2024 Jan 3;11(1):ofad703. doi: 10.1093/ofid/ofad703. eCollection 2024 Jan.
3
The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit.重症监护病房中延迟实施症状性治疗的影响。
Healthcare (Basel). 2021 Dec 25;10(1):35. doi: 10.3390/healthcare10010035.
4
Infections in Hospitalized Patients, Treatment Outcomes.住院患者的感染、治疗结果。
Antibiotics (Basel). 2021 May 25;10(6):630. doi: 10.3390/antibiotics10060630.
5
Recent Advances in the Pursuit of an Effective Vaccine.寻求有效疫苗的最新进展
Pathogens. 2020 Dec 19;9(12):1066. doi: 10.3390/pathogens9121066.
6
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study.快速抗菌药物敏感性试验对革兰氏阴性杆菌血症的影响：一项准实验研究。
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.00360-20.
7
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018.2013年至2018年美国医院常见复杂性尿路感染的抗菌药物敏感性及交叉耐药模式
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00346-20.
8
The Economic Conundrum for Antibacterial Drugs.抗菌药物的经济学难题
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.02057-19.
9
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant bloodstream infections: cefoperazone-sulbactam associated with resistance and tigecycline increased the mortality.耐碳青霉烯类血流感染患者危险因素及转归的回顾性对比分析：头孢哌酮-舒巴坦与耐药相关，替加环素增加死亡率。
Infect Drug Resist. 2018 Oct 26;11:2021-2030. doi: 10.2147/IDR.S169432. eCollection 2018.
本文引用的文献
1
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis.鲍曼不动杆菌肺炎和脓毒症中的多重耐药性、不适当的经验性治疗及医院死亡率
Crit Care. 2016 Jul 11;20(1):221. doi: 10.1186/s13054-016-1392-4.
2
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.2003年至2012年美国呼吸道和血流标本中鲍曼不动杆菌耐药性的长期趋势：一项调查研究。
J Hosp Med. 2016 Jan;11(1):21-6. doi: 10.1002/jhm.2477. Epub 2015 Sep 9.
Zotero 插件